Literature DB >> 27526959

Rapid Screening for Deleted Form of β-thalassemia by Real-Time Quantitative PCR.

Liang-Yin Ke1,2, Jan-Gowth Chang1,3, Chao-Sung Chang3,4, Li-Ling Hsieh1, Ta-Chih Liu1,3,4.   

Abstract

BACKGROUND: Thalassemia is the most common single gene disease in human beings. The prevalence rate of β-thalassemia in Taiwan is approximately 1-3%. Previously methods to reveal and diagnose severe deleted form of α- or β-thalassemia were insufficient and inappropriate for prenatal diagnosis.
METHODS: A real-time quantitative PCR method was set up for rapid screening of the deleted form of β-thalassemia.
RESULTS: Our results show that ΔΔCt between deleted form of β-thalassemia and normal individuals were 1.0674 ± 0.0713. On the contrary, mutation form β-thalassemia showed no difference with normal healthy control. The HBB/CCR5 ratio for deleted form of β-thalassemia patients was 0.48, whether normal individuals and mutation form of β-thalassemia was 1.0.
CONCLUSION: This RQ-PCR technique is an alternative rapid screening assay for deleted form of β-thalassemia. In addition, it could also identify undefined type. Our technique by using RQ-PCR to quantify gene copies is a reliable and time-saving method that can screen deleted form of β-thalassemia.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  real-time quantitative PCR; β-thalassemia

Mesh:

Year:  2016        PMID: 27526959      PMCID: PMC6817179          DOI: 10.1002/jcla.22019

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  26 in total

1.  Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler.

Authors:  N von Ahsen; E Schütz; V W Armstrong; M Oellerich
Journal:  Clin Chem       Date:  1999-05       Impact factor: 8.327

2.  Hereditary persistence of fetal hemoglobin or (delta beta)o-thalassemia: three types observed in South-Chinese families.

Authors:  Y T Zeng; S Z Huang; B Chen; Y C Liang; Z M Chang; T Harano; T H Huisman
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

3.  Molecular characterization of a novel form of (A gamma delta beta)zero thalassemia deletion in a Chinese family.

Authors:  J W Zhang; W F Song; Y J Zhao; G Y Wu; Z M Qiu; F N Wang; S S Chen; G Stamatoyannopoulos
Journal:  Blood       Date:  1993-03-15       Impact factor: 22.113

4.  The LightCycler: a microvolume multisample fluorimeter with rapid temperature control.

Authors:  C T Wittwer; K M Ririe; R V Andrew; D A David; R A Gundry; U J Balis
Journal:  Biotechniques       Date:  1997-01       Impact factor: 1.993

5.  Real-time homogeneous assay of rapid cycle polymerase chain reaction product for identification of Leptonema illini.

Authors:  T H Woo; B K Patel; M Cinco; L D Smythe; M L Symonds; M A Norris; M F Dohnt
Journal:  Anal Biochem       Date:  1998-05-15       Impact factor: 3.365

Review 6.  Molecular study and prenatal diagnosis of alpha- and beta-thalassemias in Chinese.

Authors:  T M Ko; X Xu
Journal:  J Formos Med Assoc       Date:  1998-01       Impact factor: 3.282

7.  Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia.

Authors:  S H Orkin; J M Old; D J Weatherall; D G Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

8.  The 3' breakpoint of the yunnanese (Agammadeltabeta)0-thalassemia deletion lies in an L1 family sequence: implications for the mechanism of deletion and the reactivation of the Ggamma-globin gene.

Authors:  X Q Zhang; J W Zhang
Journal:  Hum Genet       Date:  1998-07       Impact factor: 4.132

9.  Rapid diagnosis of beta-thalassemia mutations in Chinese by naturally and amplified created restriction sites.

Authors:  J G Chang; P H Chen; S S Chiou; L S Lee; L I Perng; T C Liu
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

Review 10.  Thalassemia: recent insights into molecular mechanisms.

Authors:  M H Steinberg; J G Adams
Journal:  Am J Hematol       Date:  1982-02       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.